Prosecution Insights
Last updated: October 27, 2026

Adrian Flores, USPTO Patent Examiner

Listed by the USPTO as FLORES, ADRIAN

Tech Center 3700 • Art Units: 1743 3771 3774

This examiner grants 100% of resolved cases

Analysis

FLORES, ADRIAN works in Tech Center 3700 and Art Unit 1743. The record contains 1 resolved case, with a 100.0% allowance rate and a median of 1191 days to allowance. Because the case history is limited, the allowance result should be treated as a narrow data point rather than a broad indicator of prosecution outcomes.

The interview lift is 0.0%, so the available record does not show an interview-related change in allowance outcomes. The listed companies are Edwards Lifesciences, Boston Scientific, and Alcon. The listed firms are SEAGER, TUFTE & WICKHEM, Workman Nydegger, and Bochner.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

100.0%
Allow Rate
+30.0% vs TC avg
58
Total Applications
+0.0%
Interview Lift
1191
Avg Prosecution Days
Based on 1 resolved cases, 2023–2026

Rejection Statute Breakdown

2.5%
§101 Eligibility
30.3%
§102 Novelty
58.8%
§103 Obviousness
7.6%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18686633 RADIATION COMPATIBLE EXPANDER FOR BREAST RECONSTRUCTION Non-Final OA University of Florida Research Foundation, Incorporated
18479931 APPARATUSES FOR STENT DELIVERY AND POSITIONING FOR TRANSLUMINAL APPLICATION Final Rejection Covidien LP
18774348 STENT WITH ANTI-OCCLUSION SYSTEM Non-Final OA BOSTON SCIENTIFIC SCIMED, INC.
18752094 STENT WITH ATRAUMATIC SPACER Non-Final OA BOSTON SCIENTIFIC SCIMED, INC.
18219478 Stent Delivery System Final Rejection Boston Scientific Scimed, Inc.
18426869 IN-VIVO INDWELLING STENT AND STENT DELIVERY SYSTEM Non-Final OA TERUMO KABUSHIKI KAISHA
18575587 PANCREATIC CELL RECEIVING MATRIX AND IMPROVED ARTIFICIAL PANCREAS DEVICE Non-Final OA CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
18527510 MODULAR IMPLANT WITH STABILIZATION Non-Final OA Alcon Inc.
18539973 MODULAR TRIAL IMPLANT SYSTEM Final Rejection Aesculap AG
18348620 FEMORAL CONDYLE TRIAL IMPLANT Final Rejection Aesculap AG
18742002 DELIVERY APPARATUS AND METHODS FOR IMPLANTING PROSTHETIC HEART VALVES Non-Final OA EDWARDS LIFESCIENCES CORPORATION
18418019 SENSING HEART VALVE REPAIR DEVICES Non-Final OA EDWARDS LIFESCIENCES CORPORATION
18513309 IMPLANT-COUPLED SENSORS Non-Final OA EDWARDS LIFESCIENCES CORPORATION
18511999 IMPLANTABLE FIBERS, YARNS AND TEXTILES Non-Final OA EDWARDS LIFESCIENCES CORPORATION
18464232 ANNULOPLASTY RING AND TETHER ADJUSTMENT SYSTEM Final Rejection EDWARDS LIFESCIENCES CORPORATION
18447241 HIGH STRENGTH CORDS FOR CARDIAC PROCEDURES Final Rejection EDWARDS LIFESCIENCES CORPORATION
18352120 IMPLANTABLE MEDICAL DEVICES Final Rejection EDWARDS LIFESCIENCES CORPORATION
18501258 MEDICAL IMPLANT DELIVERY SYSTEM Non-Final OA Smith & Nephew Asia Pacific Pte. Limited
18582929 PROSTHETIC HEART VALVE IMPLANT APPARATUS Non-Final OA Medtronic, Inc.
18705047 INTRA-OPERATIVELY FITTED ANTIBIOTIC SPACER SYSTEM Non-Final OA THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
18693856 TETHER FOR DELIVERY OF CARDIAC VALVE Non-Final OA Shifamed Holdings, LLC
18571977 METHODS AND IMPLANTABLE PROSTHESIS FOR RECONSTRUCTION AND/OR AUGMENTATION OF AN ANATOMICAL SHAPE Non-Final OA Davol Inc.
18686816 TISSUE BODY FORMATION DEVICE AND TISSUE BODY FORMATION METHOD Non-Final OA BIOTUBE CO., LTD.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Who Appears Before This Examiner

Top companies before this examiner

Law firms appearing most often

Frequently Asked Questions

What is examiner Adrian Flores's allowance rate?

100.0% of resolved applications examined by Adrian Flores were allowed (1 resolved cases), compared with 59.4% across Art Unit 1743 over the last five years.

Does an interview help with examiner Adrian Flores?

This examiner's interview lift is +0.0 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.

How long does examiner Adrian Flores take to allow a patent?

Applications allowed by Adrian Flores took 1,191 days on average from filing to allowance.

Which art unit does examiner Adrian Flores work in?

Adrian Flores examines applications in Art Unit 1743 in Tech Center 3700 (Medical Devices & Mechanical Engineering).

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month